Cite
HARVARD Citation
Heidenreich, A. et al. (n.d.). 2555 Impact of enzalutamide (ENZA) compared with bicalutamide (BIC) on quality of life (QoL) in men with metastatic castration-resistant prostate cancer (mCRPC): Results from the TERRAIN study. European journal of cancer. pp. S495-. [Online].